Therabron Therapeutics Receives Orphan Drug Designation in the European Union for CG367, Indicated for the Treatment of Bronchiolitis Obliterans Syndrome. For more information please click here.
ROCKVILLE, MD, November 10, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that its President and Chief Executive […]
ROCKVILLE, MD, June 2, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that the U.S. Food and Drug […]
ROCKVILLE, MD, June 1, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that President and Chief Executive Officer, […]
ROCKVILLE, MD, May 19, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, announced today the appointment of four world-renowned experts to […]
ROCKVILLE, MD, May 11, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that Aprile Pilon, PhD, Chief Scientific Officer […]
Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that it has received Notice of Allowance from the United States Patent […]
Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced the appointment of Eric I. Richman as an independent director to the […]
ROCKVILLE, MD, March 9, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced senior management team appointments. Dr. […]
ROCKVILLE, MD, March 2, 2016 — Therabron Therapeutics, Inc., a specialty biotechnology company dedicated to advancing a new standard in respiratory care, today announced presentation of data unveiling the creation […]